We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current PAVMW market cap is 3.5M. The company's latest EPS is USD -0.5488 and P/E is -1.86.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 166k | 791k | 1.05M | 1.01M | 979k |
| Operating Income | -16.48M | -15.53M | -16.38M | -14.04M | -13.69M |
| Net Income | -14.61M | -17.75M | -15.91M | -22.79M | -10.91M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 500k | 377k | 2.45M |
| Operating Income | -14.3M | -23.35M | -54.39M | -90.93M | -68.8M |
| Net Income | -16.73M | -34.56M | -50.63M | -89.26M | -66.27M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 53.68M | 42.02M | 33.12M | 37.25M | 39.41M |
| Total Liabilities | 54.51M | 57.85M | 57.14M | 57.83M | 58.06M |
| Total Equity | -830k | -15.83M | -24.02M | -20.58M | -18.64M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.24M | 19.78M | 86.98M | 53.98M | 33.12M |
| Total Liabilities | 11.88M | 20.25M | 7.56M | 43.05M | 57.14M |
| Total Equity | -4.64M | -473k | 79.42M | 10.93M | -24.02M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -29.07M | -40.16M | -52.04M | -13.11M | -24.77M |
| Investing | 959k | 941k | 758k | -42k | -45k |
| Financing | 25.53M | 25.89M | 31.17M | 19.05M | 30.67M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.36M | -21.91M | -40.59M | -70.99M | -52.04M |
| Investing | -27k | -55k | -3.72M | -4.74M | 758k |
| Financing | 11.38M | 33.01M | 104.31M | 38.21M | 31.17M |
| Market Cap | 3.5M |
| Price to Earnings Ratio | -1.86 |
| Price to Sales Ratio | 50.25 |
| Price to Cash Ratio | 6.27 |
| Price to Book Ratio | -5.13 |
| Dividend Yield | - |
| Shares Outstanding | 120.76M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 4.2 (100%) |
| Company Name | PAVmed Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.pavmed.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
